Press Release: Immunexpress : Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy
/PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today...
Read full article »
Immunexpress is a biotechnology company that develops and commercializes molecular blood biomarkers for detection and management of sepsis.
Read more